SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-07-082794
Filing Date
2007-04-17
Accepted
2007-04-17 16:11:51
Documents
3
Period of Report
2007-05-22
Effectiveness Date
2007-04-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 699971
2 GRAPHIC g20620g59f08.jpg GRAPHIC 9664
3 GRAPHIC g20620g59r91.jpg GRAPHIC 10481
  Complete submission text file 0001193125-07-082794.txt   729375
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23272 | Film No.: 07771038
SIC: 2836 Biological Products, (No Diagnostic Substances)